ParkinSong: A Controlled Trial of Singing-Based Therapy for Parkinson’s Disease

J Tamplin; ME Morris; C Marigliani; FA Baker; AP Vogel

Journal article

ParkinSong: A Controlled Trial of Singing-Based Therapy for Parkinson’s Disease

J Tamplin, ME Morris, C Marigliani, FA Baker, AP Vogel

Neurorehabilitation and Neural Repair | SAGE PUBLICATIONS INC | Published : 2019

DOI: 10.1177/1545968319847948

Abstract

Background. Communication impairment is one of the most common symptoms of Parkinson’s disease (PD), significantly affecting quality of life. Singing shares many of the neural networks and structural mechanisms used during speech and, thus, has potential for therapeutic application to address speech disorders. Objective. To explore the effects of an interdisciplinary singing-based therapeutic intervention (ParkinSong) on voice and communication in people with PD. Methods. A controlled trial compared the effects of the ParkinSong intervention with an active control condition at 2 dosage levels (weekly vs monthly) over 3 months, on voice, speech, respiratory strength, and voice-related quality..

View full abstract

University of Melbourne Researchers

Jeanette Tamplin Author

Felicity Baker Author

Adam Vogel Author

Related Projects (3)

Staying in Tune with Parkinson’s Communication: Investigating the effects of long-term participation in ParkinSong singing groups for people with Parkinson's disease and their caregivers

CHOIR PARTICIPATION TO IMPROVE WELLBEING AND RELATIONSHIP QUALITY FOR COMMUNITY-DWELLING PEOPLE WITH DEMENTIA AND THEIR PRIMARY CARE-GIVERS

An estimated 300,000 Australians live with dementia and this figure is projected to triple by 2050. Aligning with government priorities to s..

IMPROVING MOBILITY AFTER TRAUMATIC BRAIN INJURY WITH BALLISTIC STRENGTH TRAINING

Traumatic Brain Injury (TBI) is the leading cause of disability amongst young adults, many of whom have difficulty walking. Muscle weakness ..

Grants

Awarded by Parkinson’s Victoria

Funding Acknowledgements

The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: JT is funded by the National Health and Medical Research Council (NHMRC) and Australian Research Council (Fellowship ID1106603) and The University of Melbourne. MEM is funded by NHMRC grants (APP1134495, APP1104237, APP1114210, APP11523) and has a joint appointment with Healthscope and La Trobe University. CM is employed by Parkinson's Victoria. FAB is funded by NHMRC grants (APP1169867, APP1137853) and is employed by The University of Melbourne. APV is chief science officer of Redenlab who provided assistance with the acoustic analysis. He receives salaried support from the NHRMC (Fellowship ID1152223) and also receives institutional support from The University of Melbourne. This research was funded by The University of Melbourne.